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Accepted 8 July 2010AbstractObjectives: To describe the clinical characteristics of the pregnant women who were hospitalized in a tertiary referral hospital with pandemic
influenza H1N1 2009 virus infection and neonatal outcomes from October 2009 to December 2009 during which the pandemic influenza cases
peaked in Turkey.
Materials and Methods: Twenty-five pregnant women who were hospitalized with influenza-like illness and who had laboratory confirmation for
pandemic influenza H1N1 virus infection were evaluated prospectively.
Results: Of the 25 patients, 4 (16%) were in the first trimester, 8 (32%) were in the second trimester, and 13 (52%) were in the third trimester.
The median time from the onset of symptoms to the initiation of antiviral therapy was 1 day (range 1e9 days). Nineteen (76%) patients received
oseltamivir treatment. It took 1.6 days on the average for the fever defervescence after the initiation of treatment or hospitalization. Of the 14
patients who underwent chest radiography, three had findings consistent with pneumonia. The mean duration of hospitalization was 4.8 days.
Four women (16%) were admitted to an intensive care unit, but there were no maternal or neonatal deaths in this series. At the time of their
H1N1 hospitalization, seven women delivered by cesarean at 33e40 weeks gestation, two vaginally at 38 weeks gestation, and two had an
abortion at 10 weeks and 16 weeks of gestation, respectively. None of the infants had any evidence of influenza infection.
Conclusion: Pregnant women are at increased risk for complications from pandemic influenza H1N1 virus infection. Timely medical attention
with early recourse to antiviral therapy is associated with a better outcome in H1N1-affected pregnant women.
Copyright  2011, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Pandemic influenza H1N1 2009 virus infection caused
a widespread outbreak of respiratory infection. The virus,
which originated in Mexico, has spread to nearly 191 countries
and territories worldwide. On April 15 and April 17, 2009,
Centers for Disease Control and Prevention (CDC) identified
the first two cases of infection in the United States [1]. The* There are no potential conflicts of interest.
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doi:10.1016/j.tjog.2010.07.002novel virus contained a unique combination of gene segments
that had not been identified before [2,3].
The cases of the current pandemic presents with mild
symptoms, such as body aches, fatigue, chills, rhinorrhea,
conjunctivitis, shortness of breath, headache, and gastrointes-
tinal (GI) symptoms. Unlike seasonal influenza, GI symptoms,
such as diarrhea and vomiting, appear more frequently [2].
Besides these symptoms, pregnant women tend to present with
fever, cough, and/or sore throat [4]. Pregnant women experi-
ence shortness of breath more often than nonpregnant cases.
During both interpandemic seasonal influenza and previous
pandemics, it is found that pregnant women and fetus are at
increased risk for complications [5]. During the period of
April 15, 2009eJune 16, 2009, CDC reported 45 deaths from
H1N1 infection; 6 (13%) of these individuals were pregnantcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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during the second, and the remaining four during the third
trimester. All of them were previously healthy pregnant
women. They developed viral pneumonia and subsequently
acute respiratory distress syndrome (ARDS) requiring
mechanical ventilation. The CDC has implemented enhanced
surveillance for infection with H1N1 in pregnant women
because of the concerns about the severity of the disease
during pregnancy [4].
This report summarizes the cases of pandemic H1N1
influenza virus infection in pregnant women who were
hospitalized in a tertiary referral hospital from October 2009
to December 2009, during which the pandemic influenza cases
peaked in our country.
Materials and methods
The study was conducted in a tertiary referral hospital and
was approved by the institutional review board. We describe 25
pregnant women who were hospitalized in the perinatology
department for at least 24 hours with an influenza-like illness
(fever, cough, and/or sore throat) from October 2009 to
December 2009. All cases had laboratory confirmation for
pandemic H1N1 virus infection by real-time reverse transcrip-
tase polymerase chain reaction. The symptomatic patients were
isolated from other pregnant women during hospitalization. The
demographic data, information about the current pregnancy,
clinical signs, symptoms, laboratory tests, radiographic findings,
treatment courses, the time from onset of symptoms to initiationTable 1
Patients’ age, gestational age, pregnancy, and labor characteristics
Case Age Gestational age
at hospital admission
Additional com
at hospital adm
1 28 23 Preterm labor
2 22 10 d
3 24 22 d
4 17 8 Threatened abo
5 23 40 d
6 27 35 Fetal tachycard
7 18 32 Twin-preterm la
8 22 39 Fetal tachycard
9 23 17 d
10 31 17 d
11 22 16 Threatened abo
12 26 38 d
13 25 7 Emesis gravida
14 24 37 d
15 34 36 Oligohydramnio
16 27 30 d
17 28 31 d
18 27 38 Oligohydramnio
19 37 36 Asthma, HT
20 21 29 Preterm labor
21 36 10 d
22 22 27 Preterm labor
23 33 33 Thrombocytope
24 26 36 Fetal tachycard
25 33 22 d
HT¼ hypertension.of treatment, the duration of fever, and maternal and fetal
outcomes were noted.
Results
Population of Turkey was 72,561,312 on December 31,
2009 [7]. The number of pregnant women was estimated by
using the following formula [6]: the fertility rate (76 per 1000
women of reproductive age) was multiplied by nine-twelfths
of the population of women of reproductive age (15e49
years of age), which is 19,493,140 [7] because pregnancy lasts
roughly 9 months. The abortion rate (20 per 1000 women of
reproductive age) was also multiplied by a sixth of the pop-
ulation of women of reproductive age because these preg-
nancies last an average of 2 months. These numbers are added
together to estimate the number of women who are pregnant,
which gives the number of 1,176,085. It was reported that 3%
of hospital admissions were because of influenza-like illness
during the study period [8]. From October 22 to December 31,
2009, a total of 605 deaths occurred because of H1N1 influ-
enza virus infection (mortality rate 8.3 per million) [9].
Among these deaths, 36 of them were pregnant and post-
partum women (30.6 per million) [10]. Mortality rate is
reported to be three times more in pregnant and postpartum
women. This report describes the pregnant women who were
hospitalized with H1N1 influenza virus infection in a tertiary
referral hospital in Turkey. From October 1, 2009 to the end
of December 2009, 10,755 pregnant women were admitted to
the hospital. Among these pregnant women, 1031 had theplications
ission
Pregnancy outcome Neonatal outcome
d d
d d
d d
rtion d d
Delivered by cesarean 3680 g, Apgar 7/9
ia d d
bor d d
ia Delivered by cesarean 3550 g, Apgar 7/9
d d
d d
rtion Abortion d
Delivered vaginally 2770 g, Apgar 7/9
rum d d
Delivered by cesarean 3250 g, Apgar 7/9
s Delivered by cesarean 2320 g, Apgar 8/10
d d
d d
s Delivered vaginally 2920 g, Apgar 7/9
Delivered by cesarean 3000 g, Apgar 7/9
d d
Dilatation and curettage d
d d
nia Delivered by cesarean 2060 g, Apgar 7/9
ia Delivered by cesarean 2740 g, Apgar 7/9
d d
Table 2
Presenting manifestations in pregnant cases with pandemic H1N1 influenza
virus infection
Symptom Pregnant women (n¼ 25), n (%)
Fever 23 (92)
Cough 22 (88)
Sore throat 20 (80)
Myalgia 19 (76)
Dehydration 16 (64)
Vomiting 3 (12)
Dyspnea/tachypnea 2 (8)
Diarrhea 1 (4)
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virus infection was confirmed with real-time reverse tran-
scriptase polymerase chain reaction. A total of 25 pregnant
women were hospitalized during this study period. The mean
age of the patients was 26.2 years (range, 17e37 years). Nine
(36%) women were primigravidas and 16 (64%) women were
multigravidas. There were eleven (44%) nulliparous and 14
(56%) multiparous women. Of the 25 patients, 4 (16%) were
in the first trimester, 8 (32%) were in the second trimester, and
13 (52%) were in the third trimester. The mean gestational age
at admission was 26.7 weeks (range, 7e40 weeks) (Table 1).
All of the patients were nonsmokers. Only one patient had
underlying medical condition of asthma and hypertension.
Eight (32%) women reported close contact with a familyTable 3
Laboratory findings, the time from symptom onset to initiation of treatment, and t
Patient WBC
(106/L)
Hb
(g/L)
ALT
(IU/L)
AST
(IU/L)
Temperature
(C)
1 10.600 12.7 15 27 38
2 5.500 10.1 11 17 39.5
3 15.800 13.4 10 18 38.4
4 8.200 12.4 5 19 38.7
5 10.400 12.3 18 22 37.5
6 10.500 11.9 20 20 38
7 8.000 10.9 92 28 38.2
8 12.000 14 17 17 38.1
9 8.100 11.7 13 6 37.5
10 5.100 11.3 45 58 38
11 9.000 11.9 30 38 39.6
12 8.000 10.8 22 14 38.2
13 6.900 12.9 29 26 38
14 8.900 8.7 32 20 38.3
15 6.800 8.1 17 40 39.2
16 8.200 10.2 10 20 38.8
17 5.600 11.2 27 26 38.7
18 10.700 11.3 6 15 39
19 7.600 11.9 18 24 37.4
20 10.800 11.2 22 31 36.8
21 5.000 11.6 28 30 38
22 7.000 11.1 15 18 37.6
23 8.000 7.4 16 34 37
24 10.200 11.6 12 20 38.5
25 6.500 9.9 25 25 38
O2 saturations are in room air values.
Patient IDs in Tables 1 and 3 matches.
a Time from symptom onset to initiation of treatment.
b The duration of fever after the initiation of treatment or hospitalization.
ALT¼alanine transaminase; AST¼aspartate transaminase; Hb¼ hemoglobin; Wmember with influenza-like illness or pneumonia. None of the
women reported a recent travel abroad. Common symptoms
at presentation included fever, cough, sore throat, myalgia,
vomiting, diarrhea, dyspnea, tachypnea, and dehydration.
Fever more than 37.5C was reported in 92% (n¼ 23), cough
in 88% (n¼ 22), sore throat in 80% (n¼ 20), myalgia in 76%
(n¼ 19), dehydration in 64% (n¼ 16), vomiting in 12%
(n¼ 3), dyspnea and tachypnea in 8% (n¼ 2), and diarrhea in
4% (n¼ 1) of the patients (Table 2). On admission, eight
(32%) of the patients had anemia and four (16%) had leuko-
penia. The median oxygen saturation level on admission was
97% (range, 92e99%) (Table 3).
The median time from the onset of symptoms to the initi-
ation of antiviral therapy was 1 day (range, 1e9 days).
Nineteen (76%) patients received oseltamivir treatment 75 mg
twice daily for 5 days (Tamiflu; Roche, Turkey). Three of the
six patients who did not receive treatment refused to use
antiviral medication. Three other patients were also not treated
for the following reasons; fever resolved spontaneously on the
same day in one of them, the symptoms were subtle in the
other, and the third one had symptoms lasting for 9 days and
the fever subsided when she was admitted. These three
patients received only symptomatic treatment during hospi-
talization. Antibiotic treatment was given to the patients in the
intensive care unit (ICU) because they had high fever (>39C)
with infiltrations on chest X-ray. It took 1.6 days on thehe duration of fever after the initiation of treatment or hospitalization
O2 saturation
(%)
Oseltamivir
(d)a
The duration
of fever (d)b
Duration of
hospitalization (d)
97 3 2 3
98 No treatment 4 7
97 1 1 2
98 5 2 6
98 1 1 5
96 1 1 3
96 No treatment 1 3
96 4 2 4
98 2 1 4
95 No treatment 4 8
95/<80 4 3 10
98 2 2 3
99 4 2 7
94 3 2 4
96/88 1 3 10
98 3 1 5
92 2 1 4
98 1 3 7
92 1 1 5
99 No treatment No fever 3
97 1 1 5
99 No treatment 1 2
98 No treatment No fever 3
97 1 1 2
96 1 2 5
BC¼white blood cell.
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treatment or hospitalization.
Of the 14 patients who underwent chest radiography, three
had findings consistent with pneumonia. Two of these patients
had bilateral diffuse infiltrates, one patient had infiltrate
limited to lower zones.Patients admitted to ICUOf the 25 patients evaluated, four (16%) were admitted to
an ICU. One of these patients was a 37-year-old woman at 36
weeks’ gestation. She had underlying asthma and hypertension
with severe dyspnea. Two patients developed pneumonia and
ARDS. One of them was a 22-year-old woman at 16 weeks’
gestation who presented with symptoms of fever, cough, sore
throat, myalgia, dehydration, dyspnea, and tachypnea lasting
for 4 days. She had bilateral diffuse infiltrates on chest X-ray.
Oxygen saturation level was 95% on admission. She had
vaginal bleeding, which led to abortion on the next day of
hospitalization. Oxygen saturation level decreased to 80%.
She was admitted to ICU with pneumonia and subsequently
developed ARDS. The other woman with ARDS was 34-year-
old at 36 weeks’ of gestation. She was hospitalized with the
diagnosis of intrauterine growth restriction; oligohydramnios;
and flu-like symptoms of fever, cough, sore throat, myalgia,
and dehydration. She refused to take oseltamivir at first. She
delivered a 2320 g infant by caesarean section. In the post-
partum period, she developed dyspnea and tachypnea. Chest
X-ray demonstrated diffuse bilateral infiltrates. Oxygen satu-
ration level decreased to 88%. Oseltamivir was initiated after
the patient’s approval. She was admitted to ICU. She remained
intubated for 2 days in ICU. Fourth woman who was sent to
ICU was 28-year-old at 31 weeks’ of gestation presented with
fever, cough, and sore throat. Chest X-ray showed infiltrates in
the lower zone of the right lobe. Oxygen saturation level was
92%. All the patients in the ICU showed gradual improvement
in their follow up and were discharged. The mean duration of
hospitalization was 4.8 days. There was no maternal death.
At the time of their H1N1 hospitalization, seven women
delivered by cesarean at 33e40 weeks gestation, two vaginally
at 38 weeks gestation, and two had an abortion at 10 weeks and
16 weeks gestation, respectively. Four patients who did not
deliver at the time of their H1N1 hospitalization had threaten
of preterm labor with symptoms of pelvic pressure, low back
pain, and uterine contractions. These patients were treated with
bed rest, sedation, and hydration in the hospital. Fourteen
patients had ongoing pregnancies. Neonatal outcomes are
given in Table 1. None of the infants had any evidence of
influenza infection.
Discussion
Influenza viruses that cause infection in mankind are
classified as A, B, and C types. Although influenza A and B
are associated with seasonal epidemics, only influenza A is
responsible for pandemics. Influenza Avirus have basic surface
proteins, hemagglutinin, and neuraminidase. Minor mutationsof these proteins occur continuously. More dramatic changes in
the surface proteins through either mutation of nonhuman
viruses or reassortment of human and nonhuman viruses
result in creation of novel human subtypes (antigenic shift)
[4]. The novel H1N1 Type A influenza virus is responsible
for the current pandemic. It contains a unique combination of
gene segments that had not been identified before [2,3].
Respiratory droplets are the main route of transmission. It
can also be transmitted via direct contact with contaminated
surfaces and by other body fluids [11,12].
The clinical features of patients who were hospitalized with
H1N1 2009 influenza were generally similar to those reported
during peak periods of seasonal influenza and past pandemics
with an acute onset of respiratory illness [13,14]. Also, the
symptoms reported by the pregnant women were similar to
those reported by the nonpregnant general population. Unlike
seasonal influenza, the GI symptoms, such as diarrhea and
vomiting, appear more frequently. More specifically, pregnant
women tend to present with fever, cough, and/or sore throat.
These symptoms were reported in 92%, 88%, and 80% of
patients in our study, respectively.
We report the cases of hospitalized pregnant women with
H1N1 2009 influenza virus infection during the 3 months,
OctobereDecember, 2009. On the basis of the present studies,
pregnant women seem to be at increased risk for complica-
tions from pandemic H1N1 influenza virus infection, with
a higher estimated rate of hospital admission than in the
general population [6]. In a large epidemiological study from
1998 evaluating the rate of influenza-related complications
over 17 influenza seasons in women, it is reported that a high
risk for hospitalization is for influenza-related reasons in low-
risk pregnant women during the last trimester of pregnancy
[15]. The decreased colloidal oncotic pressure in the third
trimester of normal gravid participants when compared with
normal nongravid participants supports the increased propen-
sity for severe respiratory complications during this time [16].
Decreased oncotic pressure predisposes gravid women to
develop pulmonary edema. Thirteen of the 25 patients (52%)
hospitalized in our study were in the third trimester.
Eight (32%) women in the study had close contact with
a family member with influenza-like illness or pneumonia.
Sixty-eight percent of the women had no epidemiological link
(travel or contact) with the virus.
In the previous influenza pandemics of 1918 and 1957,
mortality seemed to be higher in pregnant women than in
nonpregnant population. All six deaths reported in the present
outbreak in healthy pregnant women is also noteworthy.
Although it is expected that the effects of the infection were
greatest in the women with underlying disease, in our study,
only one woman admitted to ICU had a history of asthma.
That patient had normal chest X-ray. Three patients who
developed pneumonia and admitted to ICU were healthy
pregnant women, but one of the patients in ICU had symptoms
lasting for 4 days before admission to hospital and the other
patient refused to take antiviral medication at first. These
factors caused a delay in the initiation of the treatment and
might be responsible for the rapid progression of the disease.
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with a stable course. In a recent study involving large series of
pregnant and postpartum patients who were hospitalized with
or died from 2009 H1N1 influenza, 95% of the pregnant
patients were infected in the second or third trimester, and
almost one-fifth required intensive care [17].
The novel H1N1 2009 influenza virus is sensitive to neur-
aminidase inhibitors oseltamivir and zanamivir. The benefits
of treatment with these antiviral drugs outweigh its theoretical
risk. Current CDC guidance suggests that antiviral treatment
is recommended for groups at high risk for influenza
complications from infection with H1N1 2009 influenza virus,
including pregnant women. Because of its systemic activity,
the drug of choice for pregnant women is oseltamivir. Ideally,
it is recommended to give the treatment within the first 48
hours of symptoms. It can reduce mortality in patients even
when started more than 48 hours after the onset of symptoms
[6]. Nineteen of the 25 patients (76%) in our study accepted
antiviral treatment, whereas only 3 patients refused to use the
drug because of concerns about the fetus. The median time
from the onset of symptoms to the initiation of antiviral
therapy was 1 day (range, 1e9 days). In 12 (48%) patients,
antiviral treatment was started within 48 hours of symptom
onset. It took 1.6 days on the average for the fever to subside
after the initiation of treatment or hospitalization. The mean
duration of hospitalization was 4.8 days. For the patients who
refused to take antiviral treatment, the mean duration of fever
to subside and the mean duration of hospitalization was
longer, 4 days and 6 days, respectively. For the six deaths
reported by CDC from April 15 to June 16, 2009, the length of
time from symptom onset to receipt of antiviral treatment
ranged from 6 days to 15 days with a median of 9 days. This
shows that early admission, diagnosis, and treatment of
influenza gives better results in pregnant women.
The effects of maternal influenza on the fetus are not well
understood. Viremia is believed to occur infrequently [18] and
thus vertical transmission appears to be rare [19]. None of the
fetuses born to the mothers infected with the virus have any
evidence of influenza infection. Even in the absence of
placental transmission, the fetus could be adversely affected
by influenza and its effects. Maternal first-trimester hyper-
thermia is related with neural tube defects [20]; birth anom-
alies, such as cleft lip/palate; and congenital heart defects
[21e23]. Fever during labor may cause neonatal seizures,
encephalopathy, cerebral palsy, and even neonatal death
[24,25]. Acute pyrexia and hypoxia can be associated with
fetal tachycardia, minimal variability, and decelerations in the
fetal heart rate. Thus treatment of fever with acetaminophen is
recommended. Fetal complications are related to the pertur-
bations in maternal physiology and the accompanied fetal
stress response, such as preterm premature rupture of
membranes, preterm labor, and preterm birth. The additional
complications in the current pregnancies of the patients at
admission included threaten of preterm labor in four, fetal
tachycardia in three, threaten of abortion in two, nonreactivity
on fetal cardiotocography in two, and oligohydramnios in two
patients. This suggests that the fetuses of the ill-pregnantpatients are under risk of adverse outcomes. Because most
women in the study are still pregnant, little is known about the
effects of virus on the fetus.
The CDC have listed pregnant women as a priority group
for vaccination [26]. The pregnant women are at a higher risk
for complications and can also potentially provide protection
to infants who cannot be vaccinated via the transfer of
maternal antibodies to the fetus. On September 15, 2009, four
influenza vaccine manufacturers received approval from the
Food and Drug Administration for their novel influenza A
H1N1 2009 monovalent vaccines.
Ethnic-dependent susceptibility to viral infection has been
discussed in the current pandemic, which opened a new
avenue for the issue. Among the racial and ethnic groups in the
United States, American Indians/Alaska Natives have been
hospitalized more than any other group, followed by
Hispanics, and then Black, non-Hispanics, which suggests that
H1N1 2009 influenza virus follows an ethnic pattern. One
study from New Zealand reported ethnic-related susceptibili-
ties to H1N1 virus infection [27]. A reasonable explanation for
the extremely low case fatality ratio as well as mortality rate in
China so far during the H1N1 influenza pandemic may be
ethnic-dependent susceptibility, rather than the stringent
strategies used in the prevention [28]. In addition to ethnic
subgroups, the current H1N1 2009 influenza virus also showed
age- and gender-dependent mortality rates different from other
subpopulations. Young people and pregnant women have been
assumed to be high-risk subpopulations, probably in any
ethnic groups [6]. In the present ongoing pandemic outbreak
of the H1N1, the identification of the higher susceptibility of
young people and pregnant women is a reminder that more
medical surveillance of these two subpopulations is required.
Additionally, the assessment of susceptibilities among selected
groups can help to focus on the prevention and treatment
efforts in targeting ethnic groups with high susceptibility [28].
Our experience suggests that timely medical attention with
early recourse to antiviral therapy is associated with a better
outcome in H1N1 affected pregnant women. Fever more than
39C and low oxygen saturation levels at admission should alert
the clinician about the development of a complication, such as
pneumonia, respiratory distress, and these patients should be
followed in ICU. It is important to promote strategy of vacci-
nation, basic hygienic prevention, and prompt antiviral treat-
ment of pregnant women who develop influenza symptoms.References
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